What was recalled
This page synthesizes the mechanism and product-effectiveness framework around the glucose oxidase / lactoperoxidase enzyme system in commercial pet dental products. The system is a biologically valid antimicrobial mechanism with substantial literature heritage in human oral health (Biotene human products have used this system since the 1980s) and emerging companion-animal evidence base. The framework here addresses how the system works, why it requires multiple components to function, and why commercial product effectiveness varies widely.
The native salivary LPO system is part of mammalian innate immune defense in the oral cavity. Lactoperoxidase enzyme is secreted by salivary glands at concentrations of 0.5-2 ug/mL in healthy adult saliva; thiocyanate substrate is naturally present at 0.1-3 mM concentration depending on diet (smokers and cyanogenic-food consumers have higher levels); hydrogen peroxide is produced by oral commensal bacteria (particularly Streptococcus species) during glucose metabolism, typically at low micromolar concentrations. The native system produces hypothiocyanite at concentrations sufficient to suppress oral pathogenic bacteria (Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Streptococcus mutans, Treponema denticola) without disrupting commensal community structure. The system is selectively antimicrobial for gram-negative anaerobic periodontal pathogens and acidogenic cariogenic streptococci, distinguishing it from broad-spectrum antibiotic disruption that affects commensal balance.
The commercial product enhancement adds three components to amplify the native system: (i) exogenous lactoperoxidase enzyme (typically bovine-derived LPO, providing additional enzyme to supplement endogenous salivary LPO); (ii) glucose oxidase enzyme (typically Aspergillus niger or Penicillium amagasakiense-derived; the enzyme oxidizes glucose to gluconic acid producing hydrogen peroxide stoichiometrically, providing controlled H2O2 generation for the LPO system); (iii) potassium thiocyanate substrate (supplementing salivary thiocyanate to ensure adequate substrate availability for hypothiocyanite production). The three-component formulation creates a self-regenerating antimicrobial system that operates as long as glucose substrate is present (from dietary glucose, sucrose, lactose hydrolysis products, or other fermentable carbohydrates in the oral environment).
Why it was recalled
The structural concerns have three layers. Layer one — products including only glucose oxidase without companion lactoperoxidase and thiocyanate substrate may have minimal functional effect: the LPO system requires all three components (LPO enzyme, thiocyanate substrate, hydrogen peroxide) to produce hypothiocyanite. A product including only glucose oxidase generates hydrogen peroxide but does not amplify the LPO system without companion enzymes and substrate. Some commercial products include only the GOx component, relying on native salivary LPO and thiocyanate to complete the system. The framework gap is that consumer-facing marketing may claim "lactoperoxidase enzyme system" benefits for products including only a partial system, with marketing claims outpacing demonstrated functional effect.
Layer two — contact time and dosing matter substantially: dental chew products require extended chewing time (typically 5-15 minutes) for enzyme-substrate contact with oral surfaces and biofilms; water additive products require continued ingestion across the day for repeated dosing exposure; dental gel products require direct application to teeth and gums with adequate dwell time. The framework gap is that products marketed as oral health support may not deliver functional effect if the pet does not engage the product in a manner producing adequate enzyme-substrate contact with oral surfaces. The framework is similar to the dose-response framework for any topical antimicrobial product and is generally invisible to consumer-facing marketing.
Layer three — VOHC-mechanism dental products use different mechanism and may complement rather than replace enzymatic products: the Veterinary Oral Health Council (VOHC) approves dental products demonstrating plaque or tartar reduction efficacy in standardized trials. VOHC-approved products typically rely on mechanical mechanism (kibble-shape-driven scraping action), chemical mechanism (delmopinol, chlorhexidine, sodium hexametaphosphate calcium-binding), or biofilm-disrupting mechanism (zinc citrate, polyphosphate). Enzymatic LPO system products may receive VOHC approval if demonstrating plaque or tartar reduction in standardized trials. The frameworks are complementary — mechanical, chemical, and enzymatic mechanisms can stack for broader effect — rather than substitutes. Consumer-facing marketing rarely captures the framework distinction, which can drive product selection that misses optimal coverage. See our dental chew VOHC claim controversy for additional framework coverage.
Health risks for your pet
The LPO enzyme system is generally favorable for safety profile. Lactoperoxidase and glucose oxidase are on FDA GRAS lists, with substantial human food and pet food heritage. Potassium thiocyanate at oral pet product doses is generally favorable, with theoretical cyanide-release concern only at gross overconsumption (clinical relevance minimal at commercial pet product dosing). Theoretical safety considerations: (i) allergic sensitization to bovine-derived lactoperoxidase in pets with documented dairy allergy (rare); (ii) iodine displacement — thiocyanate can interfere with thyroid iodine uptake at high doses; clinical relevance at commercial pet product dosing is minimal but pets with diagnosed hypothyroidism or thyroid disease should be discussed with veterinarian; (iii) oral microbiota shift — selective suppression of pathogenic bacteria may alter overall oral microbiota composition; clinical relevance generally favorable but pets with established commensal-overgrowth conditions warrant veterinary monitoring; (iv) hydrogen peroxide oxidative stress — the H2O2 generated by glucose oxidase is consumed by the LPO system in normal function; excess H2O2 in products with imbalanced enzyme ratios could theoretically produce mild oxidative stress on oral epithelial cells; clinical relevance minimal at commercial dosing.
The health-outcome benefits at adequate dosing and contact time include: (i) reduction in oral pathogenic bacteria including Porphyromonas gingivalis (primary periodontal disease pathogen), with consequent reduction in periodontal disease progression in dogs and cats; (ii) reduction in plaque biofilm formation and tartar accumulation; (iii) freshening of breath through reduction in volatile sulfur compound production by oral bacteria; (iv) modest reduction in gingivitis indicators (gingival index, bleeding on probing) in some trials; (v) potential supportive role in periodontal disease management alongside professional dental cleaning and concurrent oral hygiene practices.
What to do if you bought affected product
Pet owners can navigate the LPO enzyme system dental product framework meaningfully through several practical approaches: (1) look for complete three-component formulations — products listing lactoperoxidase, glucose oxidase, AND potassium thiocyanate (or its sodium equivalent) on the ingredient panel deliver the complete LPO system; products listing only glucose oxidase rely on native salivary LPO and thiocyanate to complete the system and may have reduced functional effect; (2) recognize that contact time and chewing behavior matter — dental chew products require 5-15 minute chewing time for adequate enzyme-substrate contact; supervise initial chew sessions to confirm your pet engages the product appropriately; products consumed too quickly may not deliver functional oral surface contact; (3) consider water additive products for continuous low-dose exposure — water additive formulations provide repeated dosing across the day, complementing intermittent dental chew exposure; (4) look for VOHC-approved products where available — the Veterinary Oral Health Council approval process requires demonstrated plaque or tartar reduction in standardized trials; VOHC-approved products provide evidence-quality assurance beyond ingredient inclusion alone; many enzymatic dental products are not VOHC-approved, which does not mean they are ineffective but reflects evidence-tier rather than ingredient-tier evaluation; (5) stack enzymatic, mechanical, and chemical dental products for broader coverage — LPO system enzymatic products, kibble-shape mechanical products, chlorhexidine or delmopinol chemical products, and toothbrushing all rely on different mechanisms and can be combined for complementary effect; (6) do not rely on dental products alone for periodontal disease management — established periodontal disease requires professional veterinary dental cleaning under anesthesia for full subgingival pocket access; dental products support but do not replace professional cleaning; (7) avoid LPO system products in pets with documented dairy allergy — bovine-derived lactoperoxidase may produce allergic sensitization in pets with documented bovine dairy protein allergy (rare but possible); (8) treat enzymatic dental product inclusion as one component of broader oral health management — comprehensive oral health management includes professional dental cleaning, daily toothbrushing where feasible, dental chews and water additives, kibble-shape mechanical action, and regular veterinary oral exam follow-up.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 does not score dental product effectiveness directly per our published methodology, since the rubric scope is pet food rather than dental product evaluation. Pet food with kibble-shape mechanical action approved by VOHC may receive favorable scoring within the existing rubric framework. Future rubric extension under consideration: pet food brands marketing LPO system enzyme inclusion (combined lactoperoxidase, glucose oxidase, and thiocyanate substrate) with adequate activity unit dosing would receive favorable scoring weight as oral health support signal. Related framework coverage is across our dental chew VOHC claim controversy, best dental chews guide, kibble-glaze enzyme processing controversy, and other dental and enzyme controversy pages. For now, our recommendation: look for complete three-component LPO system formulations in dental chews and water additives, recognize that contact time and chewing behavior matter substantially for functional effect, stack enzymatic with mechanical and chemical mechanisms for broader oral health support, and complement dental products with professional veterinary dental cleaning for comprehensive periodontal disease management.